Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Recruiting 1Completed 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 27Thoracic 2Gynecologic 2Sarcoma 1Head & Neck 1

Conditions

Ovarian Neoplasms 16Peritoneal Neoplasms 14Colorectal Neoplasms 11Uterine Cervical Neoplasms 9Stomach Neoplasms 9Endometrial Neoplasms 8Neoplasm Metastasis 7Urinary Bladder Neoplasms 4Triple Negative Breast Neoplasms 4Squamous Cell Carcinoma of Head and Neck 4Lung Neoplasms 4Fallopian Tube Neoplasms 4Esophageal Neoplasms 4Colonic Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Rectal Neoplasms 3Mesothelioma 3HIV Infections 3Cholangiocarcinoma 3Carcinoma, Renal Cell 3Carcinoma, Ovarian Epithelial 3Acquired Immunodeficiency Syndrome 3Uterine Neoplasms 2Uterine Cervical Dysplasia 2Squamous Intraepithelial Lesions 2Pancreatic Neoplasms 2Neoplasms 2Melanoma 2Esophageal Squamous Cell Carcinoma 2Carcinoma, Hepatocellular 2

Interventions

pembrolizumab 6Nivolumab 3Cisplatin 3Carboplatin 3Paclitaxel 2Fluorouracil 2tucatinib 1pertuzumab 1milademetan 1lenvatinib 1cemiplimab 1Trastuzumab 1Tomography, X-Ray Computed 1Ritonavir 1Radiation 1Prednisone 1Prednisolone 1Positron-Emission Tomography 1Pemetrexed 1Oxaliplatin 1Magnetic Resonance Imaging 1Leucovorin 1Itraconazole 1Gemcitabine 1Fulvestrant 1Cetuximab 1Capecitabine 1Brachytherapy 1Bevacizumab 1AZD9833 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Biliary Tract Neoplasms × Fluorouracil × Gynecologic × Clear all
NCT05489211 2026-03-19

Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)

AstraZeneca

Phase 2 Recruiting
454 enrolled
GastrointestinalGynecologic

Biliary Tract Neoplasms, Ovarian Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

NCT03314935 2025-08-12

A Phase 1/2 Study of INCB001158 in Combination With Chemotherapy in Subjects With Solid Tumors

Incyte Corporation

Phase 1/2 Completed
149 enrolled 35 charts
GastrointestinalGynecologic

Biliary Tract Neoplasms, Ovarian Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡